Stockpolly
Search
STRO · NASDAQ · Biotechnology

Sutro Biopharma (STRO)

Develops site-specific and dual-payload antibody-drug conjugates for oncology using cell-free protein synthesis.

$20.47
At close−0.35 (−1.68%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue171141326915176410121510
Cost of revenue002200000010
Gross profit171141124915176410121310
617168737680866758454340
Research & development465457626271523840373732
1517111214913109988
Selling & marketing00−2000000000
General & administrative1517131214913109988
Other expenses000−2002118100−10
Operating income−4443−57−49−68−65−69−3−48−34−30−30
−34−2119−5−7−8−8−13−9−9
Interest income5545274332222
Interest expense99998911101010910
Other non-operating income−5−12−6−8−27−4−21−3−23−1−1
Income before tax−4747−58−48−49−70−76−12−57−47−38−39
Income tax expense2160002000000
Net income from continuing operations−4931−58−48−49−72−76−11−57−47−38−39
Net income−4931−58−48−49−72−76−11−57−47−38−39
EPS, basic−$8.10$5.10−$9.50−$5.90−$5.90−$8.80−$9.10−$1.40−$6.70−$5.45−$2.94−$2.33
EPS, diluted−$8.10$5.10−$9.50−$5.90−$5.90−$8.80−$9.10−$1.40−$6.70−$5.45−$2.94−$2.33
Weighted average shares, basic66688888891317
Weighted average shares, diluted66688888891317
EBITDA−3757−49−39−39−60−461−45−35−28−27
Depreciation & amortization222222222211
EBIT−3956−51−41−41−61−47−1−46−37−29−29